Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$935M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$606M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$598M |
| 4 |
Alibaba
BABA
|
+$340M |
| 5 |
SPDR Gold Trust
GLD
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$47.4M |
| 2 |
Linde
LIN
|
+$29.9M |
| 3 |
Walmart Inc
WMT
|
+$28.5M |
| 4 |
Microsoft
MSFT
|
+$28.4M |
| 5 |
Deere & Co
DE
|
+$26.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 24.27% |
| 2 | Consumer Discretionary | 16.92% |
| 3 | Healthcare | 15.14% |
| 4 | Financials | 5.73% |
| 5 | Industrials | 3.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Pan American Silver
PAAS
$21.6B
| $342K | ﹤0.01% |
14,710
-528
| -3% | -$13.8K |
|
627
Ulta Beauty
ULTA
$24.3B
| $341K | ﹤0.01% |
+944
| New | +$341K |
|
|
DOO
628
Bombardier Recreational Products
DOO
$4.77B
| $336K | ﹤0.01% |
3,627
-131
| -3% | -$11.3K |
|
629
Tyler Technologies
TYL
$12.8B
| $333K | ﹤0.01% |
726
-1,430
| -66% | -$683K |
|
630
Equinox Gold
EQX
$13.5B
| $332K | ﹤0.01% |
50,329
-5,478
| -10% | -$36.9K |
|
631
Burlington
BURL
$23.2B
| $331K | ﹤0.01% |
+1,166
| New | +$373K |
|
632
Clean Harbors
CLH
$16.3B
| $331K | ﹤0.01% |
3,185
+102
| +3% | +$10K |
|
633
HEICO Corp
HEI
$51.4B
| $313K | ﹤0.01% |
+2,374
| New | +$313K |
|
634
Avantor
AVTR
$9.19B
| $309K | ﹤0.01% |
+7,550
| New | +$295K |
|
635
Neurocrine Biosciences
NBIX
$16.6B
| $307K | ﹤0.01% |
3,197
-2,737
| -46% | -$259K |
|
636
Eldorado Gold
EGO
$9.89B
| $303K | ﹤0.01% |
39,186
-30,813
| -44% | -$272K |
|
|
EXAS
637
DELISTED
Exact Sciences
EXAS
| $293K | ﹤0.01% |
+3,065
| New | +$324K |
|
638
10x Genomics
TXG
$6.61B
| $289K | ﹤0.01% |
+1,988
| New | +$341K |
|
639
Jazz Pharmaceuticals
JAZZ
$16.7B
| $286K | ﹤0.01% |
+2,200
| New | +$332K |
|
640
Aurinia Pharmaceuticals
AUPH
$2.11B
| $283K | ﹤0.01% |
+12,802
| New | +$203K |
|
|
CGAU
641
Centerra Gold
CGAU
$4.15B
| $283K | ﹤0.01% |
41,479
-30,871
| -43% | -$229K |
|
642
Tradeweb Markets
TW
$21.6B
| $283K | ﹤0.01% |
+3,505
| New | +$302K |
|
643
AT&T
T
$163B
| $282K | ﹤0.01% |
13,832
-980
| -7% | -$20.6K |
|
644
Centene
CNC
$32.5B
| $278K | ﹤0.01% |
4,465
-22,787
| -84% | -$1.52M |
|
645
Jack Henry & Associates
JKHY
$11.1B
| $274K | ﹤0.01% |
1,670
-2,195
| -57% | -$377K |
|
|
ERF
646
DELISTED
Enerplus Corporation
ERF
| $269K | ﹤0.01% |
33,663
+9,765
| +41% | +$60.7K |
|
647
Charles River Laboratories
CRL
$12.8B
| $268K | ﹤0.01% |
+649
| New | +$270K |
|
648
ADT
ADT
$5.58B
| $266K | ﹤0.01% |
32,938
+1,184
| +4% | +$10.9K |
|
649
News Corp Class A
NWSA
$15.4B
| $264K | ﹤0.01% |
11,222
-187,665
| -94% | -$4.44M |
|
650
GoDaddy
GDDY
$11.5B
| $261K | ﹤0.01% |
3,740
-5,159
| -58% | -$399K |
|
Similar funds
Ray Dalio's Q3 2021 Portfolio in Review
As of Q3 2021, Ray Dalio held 821 positions worth $18.3B, up 17% from $15.6B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Ray Dalio deployed $3.42B of net new capital in Q3 2021, opening 117 new positions and adding to 343 existing holdings. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 8,990,211 shares worth $70M.
By sector, the portfolio is most concentrated in Consumer Staples at 24% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Danaher, an estimated $47.4M trimmed.
- Ray Dalio's largest Q3 2021 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 8,990,211 shares worth $70M.
- Ray Dalio added most to iShares MSCI Emerging Markets ETF in Q3 2021, an estimated $935M increase.
- Ray Dalio's biggest Q3 2021 reduction was Danaher, cutting an estimated $47.4M.
- Ray Dalio fully exited Linde in Q3 2021, selling an estimated $29.9M.
- Ray Dalio's ten largest holdings make up 38% of its $18.3B portfolio in Q3 2021.
- Ray Dalio opened 117 new positions and closed 138 in Q3 2021.
- Ray Dalio's portfolio value rose 17% quarter-over-quarter to $18.3B.
Based on Bridgewater Associates's 13F filing for Q3 2021, filed 12 Nov 2021.